Company / Operating Income per Share
Annovis Bio, Inc. Operating Income per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$2.10
FY2025
5-year range
-$4.28 / -$0.96
FY2021-FY2025
Trend
+50.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 6 years, ranging from $-5.68 in FY2020 to $-0.96 in FY2021.
Based on SEC 10-K filings.
-2.10 in FY2025.
Improved from $-3.12 to $-2.10 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 50.9% year-over-year.
- Peak operating income per share was recorded in FY2021.
- Lowest operating income per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -9.28 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.10 | +50.9% |
| FY2024 | -$4.28 | -37.0% |
| FY2023 | -$3.12 | +0.8% |
| FY2022 | -$3.15 | -226.9% |
| FY2021 | -$0.96 | +83.0% |
| FY2020 | -$5.68 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026